The phenomenology and natural history of idiopathic lower cranial dystonia by unknown
Termsarasab et al. Journal of Clinical Movement Disorders 2014, 1:3
http://http://www.clinicalmovementdisorders.com/content/1/1/3RESEARCH Open AccessThe phenomenology and natural history of
idiopathic lower cranial dystonia
Pichet Termsarasab*, Donald R Tanenbaum and Steven J FruchtAbstract
Background: Many patients with lower cranial dystonia (LCrD) are misdiagnosed, and recognition of this condition
by general practitioners and dental health professionals is limited.
Methods: We define the phenomenology and natural history of idiopathic LCrD, presenting in 41 patients with the
disorder, the largest series of these patients reported to date.
Results: Phenomenology of dystonia included lower cranial and pharyngeal involvement, jaw opening and jaw
closing dystonia, and tongue dystonia. Of 25 newly described patients, 72% (18) were female, average age at onset
was 56 years, and delay before correct diagnosis was 3.8 years (0-25 years, median 2 years). Eleven patients (44%)
reported a precipitating event, the most common of which was recent dental work. Geste antagonistes were found
in 18 patients (72%). Response to treatment was mixed, indicating an unmet therapeutic need.
Conclusions: Idiopathic LCrD is often missed and institution of effective therapy is often delayed. The clinical
features and natural history of LCrD are similar to other forms of focal dystonia.
Keywords: Lower cranial dystonia, Oromandibular dystonia, Geste antagonisteBackground
Lower cranial dystonia (LCrD), focal dystonia of the mus-
cles of the lower face, jaw, tongue and pharynx, may be
seen in a variety of scenarios including tardive dystonia,
DYT6 and DYT12, and in neurodegenerative disorders
such as Wilson’s disease and neurodegeneration with brain
iron accumulation (NBIA). In contrast, isolated LCrD
occurring without other abnormalities is distinctly rare.
Many patients with LCrD are misdiagnosed, and recogni-
tion of this condition by general practitioners and dental
health professionals is limited, delaying appropriate diagno-
sis and treatment. Two hundred and twenty eight patients
with lower cranial dystonia have been reported in at least 8
prior case series/reports [1-8], however significant limita-
tions in these reports include; 1) mixing of patients with
tardive or other secondary forms of LCrD; 2) inclusion of
patients with dystonia in other body regions such as the
upper face or neck; and, 3) lack of detailed phenomenolo-
gic descriptions. We present 41 patients with idiopathic
LCrD (25 newly reported), the largest report to date of* Correspondence: Pichet.Termsarasab@mountsinai.org
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article, unless otherwise stated.idiopathic LCrD, in order to increase awareness and facili-
tate diagnosis and treatment of this unusual condition.Methods
Twenty-five patients with idiopathic LCrD were evaluated
by the senior movement disorders neurologist (SJF) over a
period of eight years. Many patients were referred by den-
tists or oral surgeons (DT). Patients with secondary dystonia
or with exposure to dopamine receptor blocking agents
were excluded. Clinical history, examination, and video re-
view were performed (PT, SJF). Age at onset, duration of
symptoms, precipitating factors, clinical phenomenology,
the presence or absence of geste maneuvers, task-specificity,
aggravating and relieving factors, and associated symptoms
and treatment response are summarized in Table 1.
To make description of this entity more comprehensive,
we have included the 16 patients with idiopathic LCrD from
our previous publication in our series [4]. We excluded
three patients from the previous publication who also had
blepharospasm. The study was approved by the Mount Sinai
Institutional Review Board. Video written-informed consent
was obtained from all patients. We did not obtain separated
informed consent as this is a retrospective chart review.ntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Table 1 Summary of clinical features including phenomenology of 41 patients with idiopathic LCrD












1 F 65 2 Jaw Jaw opening Speech, eating,
chewing
Dental work None None LD (no), BoNT
(no, dysphagia),
THP (no), CLZ (no),
baclofen (unknown)
N




None None THP (yes, 2–4 mg/d) N
3 F 59 2 Jaw Jaw opening
and protrusion






Pain/clicking in TMJ THP (no) N
4 F 53 0 Jaw Jaw opening Speech – > eating None Plastic/tongue
depressor between
teeth > holding jaw
R ear clicking, lower
jaw pain






5 F 46 2 Jaw Jaw opening Speech – > eating None Plastic between
teeth, holding jaw

















None THP (yes, 6–15 mg/d) N
7 F 73 1 Jaw R jaw deviation At rest None Plastic between
teeth on the L
None THP (no), CLZ
(1 mg/d, unknown)
N















Jaw pain CLZ (unknown) N
10 F 56 2 Jaw R jaw deviation Speech, chewing None Plastic between
teeth on the right
and in front, holding
jaw
Mild pain THP (yes, 6 mg/d) N





None THP (unknown) N






None THP (unknown) N





None None Straw in his mouth,
lightly touching lips
























Table 1 Summary of clinical features including phenomenology of 41 patients with idiopathic LCrD (Continued)







Speech – > eating,

































or a pen cap
between teeth











None None None LD (no), CLZ
(yes, mild, 3 mg/d),
BoNT (no), THP (unknown)
N




















started 2 years after.
TBZ (no), CLZ (no),
THP (unknown)
N









20 F 63 1 Jaw Jaw opening,
jaw protrusion
Speech (words with
an "r" or "l", at rest
Holding a plastic




LD (no), LZP (no),
Baclofen (unknown)
N
21 M 45 1 Jaw Jaw closing, jaw
protrusion and L
jaw deviation

























23 M 51 1 Jaw L jaw deviation,
mild jaw
protrusion
At rest None Firm pressure on R
cheek, holding
object between
teeth on the L side
























Table 1 Summary of clinical features including phenomenology of 41 patients with idiopathic LCrD (Continued)






























between teeth (L >
R), touching jaw/
chin lightly






CLZ (no, 1.5 mg/d),
THP (no, 2 mg/d,
dose inadequate)
N
26 M 50 Tongue Tongue rolling Speech Toothpick in mouth;
touch lips with finger
TBZ (no); THP (unknown) Y; good
response
27 M 38 Jaw L jaw deviation Speech, chewing Pipette between left
molars; touch left
jaw
CLZ, THP (no) Y; no
response
28 F 60 Jaw Jaw closure Non-specific, worse
with speech
Touch L cheek; plastic
tube between teeth
BoNT (unknown) N
29 F 43 Jaw Jaw closure and
L jaw deviation





BoNT (yes) Prior device;
good
response
30 M 41 Jaw Jaw closure French horn – >
speech, drinking
Bite plate; straw
between teeth on L
BoNT, CLZ, baclofen,
THP (no to all)
Y; brief
response
31 F 41 Jaw Jaw protrusion
and left jaw
deviation
Speech Straw between teeth,
L > R
BoNT (unknown) Y (bite
blocks); help
when bite
32 M 33 Lip Lip pulling to the
corners of the
mouth
Speech Straw between upper
lip-teeth; hold upper
lip with 2 fingers
THP (yes, 6–18 mg/d) N





Non-specific Straw between teeth
on either side
CLZ (yes, 0.5 mg/d),
BoNT (no)
N
34 M 64 Pharynx,
larynx
Pulling Paradoxical; worse
at rest, speech better
Plastic between teeth CLZ (unknown) N










36 F 66 Tongue Tongue pushing
against teeth
(protrusion?)






























Table 1 Summary of clinical features including phenomenology of 41 patients with idiopathic LCrD (Continued)
38 M 44 Tongue Tongue rolling Flute – > speech Plastic pipette in
cheek
THP (yes, 4–6 mg/d) N
41 M 30 Embouchure Lowering,
protrusion
Trombone Touch chin or L side
of face
None N




at rest, speech better





43 F 42 Jaw, lips Jaw and lip
opening
Speech, chewing Touch R temple CLZ, THP, BoNT,
baclofen (no to all)
Y; brief
response
Data on our new patients (number 1–25) is presented with previously published patients (number 26–43; shown in italics).
Legend: Patient number, gender, age at onset (years), duration of the disease (years), areas that are affected (arrow shows the pattern of spreading from one region to another), primary movement, task specificity,
precipitating events, sensory trick, associated symptoms, treatment employed, and trial of oral devices and response are listed in columns. Patients 1 to 25 were new and patients 26 to 43 (shown in italics) were
previously published [4]. Patients 39, 40 and 44 were excluded due to co-existing blepharospasm. There is no information on precipitating event in patients 26 to 43.
M, male; F, female; L, left; R, right; mvmt, movement; invol., involuntary; >, had greater effect than; fx, fracture; wk, week; mo, month; y, year; TMJ, temporomandibular joint; sl, slight; wt, weight; b/l, bilateral; LD,
levodopa; BoNT, botulinum toxin injections; THP, trihexyphenidyl; CLZ, clonazepam; mg/d, milligram per day; DZP, diazepam; LVT, levetiracetam; TBZ, tetrabenazine; N, no; Y, yes. In treatment column, response is
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Of 25 patients identified in the current series, 18 (68%)
were female, and the mean age at evaluation was 60 years
(range 44–82). Mean age at onset of symptoms was 56
(range, 25–78), 59.5 years in women and 48.6 in men.
Only one patient had a positive family history, a patient
with a son with an identical phenotype of rightward jaw
deviation. The most common primary phenotype was a
mixed dystonia (12 patients, 48%). Of the mixed pheno-
types, jaw opening was the most common primary
movement (4 patients). The second most common pri-
mary phenotype was jaw deviation (6 patients, 24%),
followed by jaw opening (4 patients, 16%). Of 6 patients
with pure jaw deviation, the jaw was deviated to the left
in 4 patients and to the right in 2 patients. There was
one patient each with pure jaw protrusion, pure tongue
protrusion and pharyngeal/laryngeal dystonia.
In almost all patients (24/25, 96%), dystonia was task-
specific. The most common task triggering dystonia was
speaking (16/25, 64%), followed by eating or chewing (15/
25, 60%). Thirteen patients had dystonia related to both
speaking and eating/chewing. Four of these 13 demon-
strated a pattern of progression of task-specificity, with
dystonia initially involving speech and then progressing
over time to involve eating as well. Some patients who had
dystonia with chewing had difficulty specifically with hard
objects. A few patients with dystonia related to speaking
described a trigger with particular sounds, such as “r” or “l”
sounds in one patient, and “ke” or “ge” sounds in another.
Dystonia also occurred at rest in 9 patients.
Eleven patients (44%) reported a precipitating event be-
fore onset of dystonia, the most common of which was
dental work within the preceding several weeks (5 patients,
20%). Two precipitating events related to injury or manipu-
lation of maxillofacial bones included a traumatic mandibu-
lar fracture after a fall and maxillary bridge replacement.
The latter patient was required to hold her mouth open
for 2 hours while the temporary bridge was fit. Other pre-
cipitating events included a history of a left subdural
hematoma 3 weeks prior, and a skull fracture with exten-
sive left orbital bone damage from a car accident.
Geste antagonistes were found in 18 patients (72%). The
most common one observed on examination was holding
an object such as a piece of plastic, a tongue depressor,
syringe or straw between the teeth, in 17 out of 18 pa-
tients. Six patients demonstrated marked side specificity
of the geste: improvement when placing the trick device
between teeth on one side but not the other side.
Complete data on side specificity in all patients could not
be assessed due to lack of testing. There was no clear rela-
tionship between the phenomenology of dystonia (for ex-
ample, the side that the jaw deviated to) and the side
specificity of this geste antagoniste. Ten patients also
had improvement in dystonia when lightly touchingthe jaw, chin or face with finger(s) or a hand. One of these
ten patients had improvement even when he imagined
holding his jaw. Three reported improvement with chew-
ing gum, one of which had side specificity on the left.
Stress and fatigue were aggravating factors in some pa-
tients. The most common associated symptom was jaw
pain (5 patients, 20%). A clicking noise in the jaw or ear
was found in 4 patients (16%). Dysphagia was found in 2
patients: one had severe weight loss and the other had
dysphagia only with liquids. Two patients reported mouth
ulcers or bleeding from biting buccal mucosa.
Oral medication and botulinum toxin injections were
employed in treatment. Oral medications included tri-
hexyphenidyl (21 patients, 84%), clonazepam (15 patients,
60%), baclofen (5 patients, 20%) and levodopa (4 patients,
16%). Propranolol, carbamazepine and clonidine were
each also used in one patient. The most common daily
dose of trihexyphenidyl was 6 mg/day in 10 patients
(range 1–19 mg). Of 21 patients treated with trihexyphe-
nidyl, three had response with very good benefit at the
dose of 2–15 mg/day, seven did not have benefit and the
response was unknown in 11 patients. Of 15 patients
treated with clonazepam, two had response that was only
mild at the dose of 1.5-3 mg/day, nine had no response
and the response was unknown in four patients. Baclofen
was employed in 5 patients, none of whom had a good re-
sponse, three had no response and the response was un-
known in the other two patients. Of data available, the
dose of baclofen employed was 10–30 mg/day.
Ten patients (40%) underwent botulinum toxin (BoNT)
injections. The sites of the injections depended on the pri-
mary movement, mostly external or internal pterygoids.
There was a response that was only mild in three patients,
one of whom continued to have significant disability. Five
patients had no response to BoNT injections and the re-
sponse was unknown in two patients.
With regards to side effects, confusion, mild tendency to
sadness and anxiety each were found in one patient each
taking trihexyphenidyl at 3–6 mg/day. Side effects from
clonazepam included anxiety, confusion/memory problem,
and sedation, each found in one patient taking the dose of
1–1.5 mg/day. One patient who received BoNT injections
was complicated by marked dysphagia. Depression and
rash each were found in one patient taking tetrabenazine.
Table 2 illustrates the comparison of results combining
our 25 new patients with 16 patients from the previously
published series, when analyzing the new patients com-
pared to all 41 patients. The results with regards to sex
predilection, areas affected, primary movement, task-
specificity, geste antagoniste, treatment employed and
response to the treatment were similar. Of note, 3 pa-
tients from the previously published series had task spe-
cificity related to performance on a brass or woodwind
musical instrument (embouchure dystonia).
Table 2 Comparison of results between new patients and combined data with the previous publication
New patients Combined data
Number of the patients 25 41
Sex Female 18/25 (72%) Female 24/41 (58.5%)
Male 7/25 (28%) Male 17/41 (41.5%)
Female/male (F/M ratio) 2.6:1 1.4:1
Average age at onset (years) 56 53.3
In female subgroup 59.5 48.6
In male subgroup 48.6 47.2
Areas affected
Jaw only (including mixed primary movements of jaw) 15 (60%) 20 (48.8%)
Lip or perioral only 0 (0%) 2 (4.9%)
Tongue only 2 (8%) 5 (12.2%)
Pharynx/larynx 1 (4%) 2 (4.9%)
Mixed 7 (28%) 11 (26.8%)
Jaw and tongue 4 (16%) 6 (14.6%)
Primary movement
Pure jaw deviation 6 (24%) 7 (17%)
to the left 4 (16%) 5 (12.2%)
Pure jaw opening 4 (16%) 4 (9.8%)
Mixed 12 (48%) 17 (41.5%)
Task specificity
Speech 18 (72%) 27 (65.9%)
Eating/chewing 15 (60%) 18 (43.9%)
At rest 9 (36%) 11 (26.8%)
Musical instrument 0 (0%) 4 (9.8%)
Geste antagoniste 18 (72%) 34 (82.9%)
Object between teeth 17 (68%) 31 (75.6%)
with side specificity 6 (24%) 8 (19.5%)
Holding body part lightly 10 (40%) 15 (36.6%)
with side specificity 4 (16%) 8 (19.5%)
Treatment
THP 21 (84%) 29 (70.7%)
good response 3 (12%) 5 (12.2%)
CLZ 15 (60%) 22 (53.7%)
good response 2 (8%) - all mild 4 (9.8%)
Baclofen 5 (20%) 7 (17%)
good response 0 (0%) 0 (0%)
BoNT 10 (40%) 18 (43.9%)
good response 3 (12%) - all mild 5 (12.2%)
Dental device 4 (16%) 11 (26.8%)
good response 0 (0%) 2 (4.9%)
Legend: Data on our 25 patients and combined 41 is shown in the middle and right columns, respectively. Number of patients, sex, average age at onset, areas
affected, primary movement, task specificity, geste antagoniste, and treatment employed are listed in the left column. With regards to areas affected, note that
“jaw only” group also includes patients with mixed primary movement of the jaw such as mixed jaw opening and protrusion. With regards to geste antagoniste,
data on side specificity, either left or right, is shown. Numbers of the patients on each treatment modality and the ones with a good response are shown. Data on
“no-response” and “unknown” group is not shown here. All numerical data (except average age at onset) represent numbers of the patient with percentage (in the
brackets) of total number of the patients in each group, 25 and 41, respectively, are shown.
THP, trihexyphenidyl; CLZ, clonazepam; BoNT, botulinum toxin injections.
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• Description of the abnormal movement or sensation
• Precipitating factor (especially history of recent dental work or
maxillofacial trauma) lower cranial
• Aggravating and relieving factors
• Associated symptoms such as pain, jaw clicking
• Sensory tricks
• History of previous treatment such as dental prosthesis
• History of secondary causes of dystonia especially dopamine receptor
blocking agent exposure
Examination
• Identify the primary movement(s)
o Jaw in each axis: opening/closing, lateral deviation (left/right),
protrusion/retraction
o Tongue: protrusion/retraction, torsion
• Determine task specificity (dystonia occurs with speaking,
eating/chewing and/or at rest)
• Identify sensory tricks: light touch, placing objects such as plastic
syringe or tongue depressor between teeth on each side and in the
center
• Assess evidence of dystonia in other body parts especially in upper
cranial region, voice and neck
Legend: Practical guideline in history taking and physical examination of
patients with LCrD is described.
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(see video in Additional file 1).
Patient 2: pure jaw deviation
A 72-year-old woman suffered a traumatic mandible frac-
ture after a fall. Her jaw was wired shut for six weeks. On
recovering from surgery, she immediately became aware
of a change in the way her jaw felt. She noticed that her
right molars were no longer contacting one another when
she chewed; eating, chewing and speaking were difficult,
and her jaw would move spontaneously to the left. She
had no history of neuroleptic or anti-emetic exposure. She
was not aware of any sensory tricks. Examination revealed
mild jaw dystonia with leftward shift, mildly accentuated
by speaking. There was no clear change with holding a
plastic syringe between her teeth on either side. She was
started on trihexyphenidyl 2 mg daily with titration to
2 mg twice a day. She had a very good sustained response
even when decreasing the dose down to 2 mg/day.
Patient 17: pure lingual dystonia
A 57-year-old man developed involuntary movements of
the tongue over a period of two years. He did not iden-
tify any sensory tricks, and there was no history of pre-
cipitating factors, neuroleptic or antiemetic exposure.
Examination revealed mild protrusion and rotation of
the tongue in a 90-degree clockwise fashion. Movements
were not triggered by tasks, and indeed were absent
when he spoke. We were not able to identify any sensory
tricks such as placing a tongue depressor or a small plas-
tic bite block between his teeth. He had been treated
with botulinum toxin injections, without apparent bene-
fit, and with clonazepam, with mild benefit at the dose
of 3 mg/day. He was then started on trihexyphenidyl with
a slow titration schedule up to 6 mg/day (in 3 divided
doses) without either benefits or side effects. We increased
the dose to 12 mg/day (in 3 divided doses). The response
with this dose was unknown as further follow-up informa-
tion was not available.
Patient 3: mixed dystonia
A 61-year-old woman underwent a maxillary bridge
replacement four years prior to being seen. A tempor-
ary bridge was made and her mouth was open for
two hours while this was fit. Since that time, she felt
that her jaw alignment was incorrect, and she devel-
oped difficulty with her speech, jaw pain and clicking
in her temporomandibular joints (TMJs). In the last
year she noticed movements involving the tongue and
jaw, initially limited to the task of speaking. Over time,
movements spread to involve eating and chewing,
sparing drinking. There was no history of neuroleptic
or anti-emetic exposure. She saw a dentist and tried mul-
tiple oral devices without benefit. Examination revealeda tendency of the jaw to open and push forward an-
teriorly at rest. When she spoke, movements were
further activated causing mild dysarthria. Holding a
piece of plastic between her teeth immediately im-
proved her speaking. She was started on low dose tri-
hexyphenidyl with slow titration to 2 mg three times
daily without benefit. We then referred her for botu-
linum toxin injections.
Discussion
In this series, the largest of such patients reported, idio-
pathic LCrD was more common in women than men
(2:1). This is similar to the pre-existing literature on LCrD
and other forms of focal dystonia such as cervical dystonia
(female/male; F/M ratio 1.2-1.92:1) [9-17], blepharospasm
(F/M ratio 1.35-2:1) [9,18-20], spasmodic dysphonia (F/M
ratio 1.35-15:1) [9,21-24], and oromandibular dystonia
3.28:1 [9], but opposite to what is seen in writer’s cramp
(F/M ratio of 1:2) [9]. Almost half of our patients had a
mixed phenotype and the other half were simpler (pure).
In the group with pure phenotype, the most common pri-
mary movement was jaw deviation, whereas jaw opening
was the most common phenotype of mixed phenotype.
Jaw protrusion, as well as tongue and pharyngeal dystonia
was much less common.
Termsarasab et al. Journal of Clinical Movement Disorders 2014, 1:3 Page 9 of 10
http://http://www.clinicalmovementdisorders.com/content/1/1/3The anatomy and function of the jaw is unique. Em-
bryologically the jaw muscles are derived from presomi-
tic mesoderm of the first branchial arch [25], whereas
limb muscles are derived from somites. The multiple
functions of the jaw are complex as well. Chewing re-
quires complex coordinated movements of various jaw
muscles. Masticatory myosin is expressed in the jaw, and
during evolution it is replaced with other types of my-
osin to tailor for eating habits or types of diet [26]. In
humans jaw closing muscles contain rich muscle spindle
innervation whereas jaw-opening muscles do not [27,28],
possibly due to the strong proprioceptive input related to
jaw closure for modifying bite strength. One possible rea-
son for this is the evolutionary pressure that modifies the
bite. For example, humans can modulate bite strength to
match different consistencies of food, and many mammals
and vertebrates must be able to exert tremendous force
with the jaw to capture prey, but also modify their bite so
as to gently carry their young. These unique features of
the jaw muscles might explain the common and often ro-
bust sensory gestes observed in our patients.
Task specificity is a nearly universal feature of LCrD,
and the most common triggering tasks were speaking,
followed by eating or chewing. Often dystonia began with
speaking, and then spread to eating or chewing. We did
not observe other patterns of spread of dystonic tasks. Re-
cent dental work or oral trauma may precipitate LCrD, as
can manipulation of the facial bones, especially the maxilla
and mandible. There may be a role of “osseoperception”
[29,30]; afferent signal from periodontal mechanoreceptor
is required in fine motor control of the mandible such as
chewing or jaw closing. However, this concept can explain
only some, but not all, patients such as in the ones who
had tooth extraction as a precipitating event. In addition,
it does not explain non-jaw related dystonia such as lin-
gual dystonia after dental work.
3/4 of our patients possessed a geste antagoniste, and
all of those had improvement of LCrD by holding an ob-
ject between their teeth. Some improved when lightly
holding the chin and jaw, and occasionally with imagin-
ation of the sensory trick. This feature is a key diagnostic
aide, and the presence or absence of a sensory trick
should be investigated in all such patients. The numbers
are too small to support a clear relationship between the
presence of a geste antagoniste and treatment response
in our series. Of 9 patients with response to at least one
treatment modality, six had at least one sensory trick,
whereas 12 of 16 patients without treatment response
did not have an identified sensory trick.
The most common treatment used in our patients was
trihexyphenidyl, the response of which was more robust
than the other modalities, but still disappointing. None of
the patients had good response to baclofen or dental de-
vice in our series. Response to botulinum toxin injectionwas less robust than in other series, for reasons that are
not clear.
Conclusion
Idiopathic LCrD is often missed and institution of effect-
ive therapy is often delayed. The clinical features and nat-
ural history of LCrD are similar to other forms of focal
dystonia.
We offer the following practical guidelines for clinicians
who evaluate patients with LCrD. Table 3 illustrates clin-
ical approach to patients with LCrD. The differential diag-
noses of idiopathic LCrD includes other primary dystonia
(such as primary segmental dystonia, Meige’s syndrome),
secondary dystonia (such as tardive dystonia from dopa-
mine receptor blocking agents, infectious dystonia includ-
ing anti-NMDA encephalitis), heredodegenerative dystonia
(such as X-linked dystonia parkinsonism or Lubag’s dis-
ease, neuroacanthocytosis, Lesch-Nyhan syndrome, SCA 8
[31], cerebrotendinous xanthomatosis) [32], and pseudo-
dystonia. Pseudodystonia in the differential diagnoses of
LCrD include Isaac’s syndrome, tetanus, and musculoskel-
etal abnormalities such as Satoyoshi syndrome.
We hope that this paper will call attention to this en-
tity, and aide dental professionals, general physicians
and neurologists in securing the correct diagnosis.
Additional file
Additional file 1: Patient 2 demonstrates pure left jaw deviation,
accentuated by speaking. Patient 3 demonstrates jaw-opening dys-
tonia and mild jaw protrusion, more prominent when speaking. Dystonia
improved when a plastic syringe is placed between her teeth. Patient 23
has prominent left jaw deviation and mild jaw protrusion at rest. Dystonia
improves when he places a plastic syringe between his teeth on the left,
but not on the right, and holding firm pressure on the right cheek.
Patient 1 demonstrates jaw opening dystonia when chewing. Patient 4
has jaw opening dystonia, worse when speaking and chewing. Whispering
and singing are easier for her. Dystonia was mildly improved when holding
a lower jaw. Dystonia and speech were markedly improved when placing a
plastic syringe or a tongue depressor between her teeth. Patient 5 shows
severe jaw opening dystonia, triggered when she speaks. Dystonia is
improved when holding bilateral jaw with her hands or an examiner’s
hands. Patient 10 shows pure right jaw deviation, accentuated by speaking.
Dystonia is improved when holding her lower jaw with a finger, and placing
a plastic syringe between her teeth on the right and in front, but not on the
left. Patient 25 has mouth closure with slight jaw opening and protrusion
when speaking, worse when praying. Dystonia is better when placing a
tongue depressor between his teeth. Dystonia was also accentuated by
chewing but to a lesser degree than speaking.
Abbreviations
BoNT: Botulinum toxin; F/M: Female/male; LCrD: Lower cranial dystonia;
NBIA: Neurodegeneration with brain iron accumulation; NMDA: N-methyl-D-
aspartate; SCA: Spinocerebellar ataxia; TMJ: Temporomandibular joint.
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